This content requires a premium subscription.
Please log in or subscribe to continue.
FierceBiotech Radio
The future of 'female Viagra,' the return of Allergan buyout chatter, and an overuse of the word 'allegedly'
Released: Aug 20, 2015
Fierce editors discuss the controversial FDA approval of the first libido drug for women, what Allergan should buy next, and Retrophin's lawsuit against former CEO Martin Shkreli.
The future of 'female Viagra,' the return of Allergan buyout chatter, and an overuse of the word 'allegedly'
